ProQuad Dose Selection Study (V221-011)(COMPLETED)

Clinical trial NCT00986232 · COMPLETED

Trial details

NCT number: NCT00986232
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Measles Mumps Rubella Varicella

Start date: 1999-04-01
Primary completion: 2000-04-01
Enrollment: 1551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.